# An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

> **NCT04742699** · PHASE4 · COMPLETED · sponsor: **Kurume University** · enrollment: 97 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Lemborexant (LEM) 5 mg (Z-Drug-mono cohort)
- **DRUG:** Lemborexant (LEM) 5 mg (SUV-mono cohort)
- **DRUG:** Lemborexant (LEM) 5 mg (SUV-combination cohort)
- **DRUG:** Lemborexant (LEM) 5 mg (RMT-combination cohort)

## Key facts

- **NCT ID:** NCT04742699
- **Lead sponsor:** Kurume University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-24
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-06-20
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2023-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04742699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04742699, "An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04742699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*